miRNA oligonucleotide and sponge for miRNA-21 inhibition mediated by PEI-PLL in breast cancer therapy-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

miRNA oligonucleotide and sponge for miRNA-21 inhibition mediated by PEI-PLL in breast cancer therapy

Published:2015-10 Issue: Volume:25 Page:184-193
ISSN:1742-7061
Container-title:Acta Biomaterialia
language:en
Short-container-title:Acta Biomaterialia

Author:

Gao Shiqian,Tian Huayu,Guo Ye,Li Yuce,Guo Zhaopei,Zhu Xiaojuan,Chen Xuesi

Funder

National Natural Science Foundation of China

Publisher

Elsevier BV

Subject

Molecular Biology,Biomedical Engineering,Biochemistry,Biomaterials,General Medicine,Biotechnology

Reference32 articles.

1. Breast cancer statistics, 2013;DeSantis;Ca-Cancer J. Clin.,2014

2. Systematic screen of chemotherapeutics in Drosophila stem cell tumors;Markstein;Proc. Natl. Acad. Sci. USA,2014

3. Stimulus-responsive polyplexes with drug and gene co-delivery;Chen;Chem. J. Chin. Univ.,2013

4. MicroRNAs: genomics, biogenesis, mechanism, and function;Bartel;Cell,2004

5. Post-transcriptional regulation in osteoblasts using localized delivery of miR-29a inhibitor from nanofibers to enhance extracellular matrix deposition;James;Acta Biomater.,2014

Cited by 92 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Engineering supramolecular dynamics of self-assembly and turnover of oncogenic microRNAs to drive their synergistic destruction in tumor models;Biomaterials;2024-09

2. Intracellular nonenzymatic in situ growth of layered nanosheet DNA architectures based on palindrome-chained dumbbell probes for miRNA imaging;Talanta;2024-09

3. miRNA-targeting oligonucleotide constructs with various mechanisms of action as effective inhibitors of carcinogenesis;Biological Products. Prevention, Diagnosis, Treatment;2024-06-04

4. The challenges and potential of microRNA-based therapy for patients with liver failure syndromes and hepatocellular carcinoma;Expert Opinion on Therapeutic Targets;2024-03-03

5. Nanosponge-mediated oligonucleotide delivery: A cutting-edge technology towards cancer management;Journal of Drug Delivery Science and Technology;2024-01

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3